PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
Publication
, Journal Article
Reardon, DA; Sathornsumetee, S; Vredenburgh, JJ; Rich, JN; Desjardins, A; Quinn, JA; Mathe, A; Gururangan, S; Friedman, AH; Friedman, HS
Published in: NEURO-ONCOLOGY
April 1, 2009
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
April 1, 2009
Volume
11
Issue
2
Start / End Page
231 / 231
Location
Tokyo, JAPAN
Publisher
DUKE UNIV PRESS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reardon, D. A., Sathornsumetee, S., Vredenburgh, J. J., Rich, J. N., Desjardins, A., Quinn, J. A., … Friedman, H. S. (2009). PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME. NEURO-ONCOLOGY, 11(2), 231–231.
Reardon, David A., Sith Sathornsumetee, James J. Vredenburgh, Jeremy N. Rich, Annick Desjardins, Jennifer A. Quinn, Alyssa Mathe, Sridharan Gururangan, Allen H. Friedman, and Henry S. Friedman. “PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME.” NEURO-ONCOLOGY 11, no. 2 (April 1, 2009): 231–231.
Reardon DA, Sathornsumetee S, Vredenburgh JJ, Rich JN, Desjardins A, Quinn JA, et al. PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME. NEURO-ONCOLOGY. 2009 Apr 1;11(2):231–231.
Reardon, David A., et al. “PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME.” NEURO-ONCOLOGY, vol. 11, no. 2, DUKE UNIV PRESS, Apr. 2009, pp. 231–231.
Reardon DA, Sathornsumetee S, Vredenburgh JJ, Rich JN, Desjardins A, Quinn JA, Mathe A, Gururangan S, Friedman AH, Friedman HS. PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2009 Apr 1;11(2):231–231.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
April 1, 2009
Volume
11
Issue
2
Start / End Page
231 / 231
Location
Tokyo, JAPAN
Publisher
DUKE UNIV PRESS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences